Why is Kobo Biotech falling/rising?

As of 22-Jul, Kobo Biotech Ltd is experiencing a decline in its stock price, currently at Rs 2.41, which reflects a decrease of Rs 0.12 or 4.74%. The stock has underperformed significantly, with a 1-week return of -9.06% and a 1-year return of -40.35%. Today's performance indicates that it is trading lower than all key moving averages, and it is close to its 52-week low, being only 3.73% away from Rs 2.32. The company has not declared results in the last six months, which raises concerns about its long-term fundamental strength. Additionally, it has shown poor growth metrics, including a net sales decline of -100.00% over the last five years and a high debt-to-equity ratio, contributing to its classification as a strong sell.
In the broader market context, Kobo Biotech's recent performance contrasts sharply with the benchmark, as the Sensex has only declined by -0.47% over the past week. This underperformance is further highlighted by the stock's negative returns over various periods, including a -52.37% return over the last three years compared to a +46.57% return for the benchmark. The stock's liquidity appears adequate, with a rise in delivery volume, but the overall sentiment remains bearish due to the company's weak financial results and lack of recent disclosures, which have led to increased risk perceptions among investors.